NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 143 filers reported holding NEOGENOMICS INC in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,621,000 | +21.2% | 1,589,352 | +16.3% | 0.00% | 0.0% |
| Q3 2016 | $11,236,000 | +3.4% | 1,366,920 | +1.1% | 0.00% | 0.0% |
| Q2 2016 | $10,870,000 | +106.9% | 1,352,021 | +73.5% | 0.00% | +100.0% |
| Q1 2016 | $5,253,000 | -11.2% | 779,314 | +3.6% | 0.00% | 0.0% |
| Q4 2015 | $5,918,000 | +67.3% | 751,997 | +21.8% | 0.00% | 0.0% |
| Q3 2015 | $3,538,000 | +41.6% | 617,411 | +33.7% | 0.00% | – |
| Q2 2015 | $2,499,000 | +2476.3% | 461,848 | +2121.2% | 0.00% | – |
| Q1 2015 | $97,000 | +870.0% | 20,793 | +754.3% | 0.00% | – |
| Q4 2014 | $10,000 | -37.5% | 2,434 | -20.7% | 0.00% | – |
| Q3 2014 | $16,000 | -98.5% | 3,071 | -99.0% | 0.00% | – |
| Q1 2014 | $1,087,000 | -3.0% | 313,266 | +1.1% | 0.00% | – |
| Q4 2013 | $1,121,000 | +13.5% | 309,727 | -6.0% | 0.00% | – |
| Q3 2013 | $988,000 | -21.7% | 329,326 | +3.9% | 0.00% | – |
| Q2 2013 | $1,262,000 | – | 316,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |